Ilyang Pharmaceutical Co.,Ltd (KRX: 007570)

Ilyang Pharmaceutical Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12,375	9,485	59,597	47,732	41,341	35,896
Short-Term Investments	12,250	10,276	5,419	34,111	1.77	0.87
Trading Asset Securities	-	-	-	231.78	269.1	-
Cash & Short-Term Investments	24,625	19,761	65,016	82,075	41,612	35,897
Cash Growth	66.57%	-69.61%	-20.78%	97.24%	15.92%	30.36%
Accounts Receivable	68,349	62,701	60,151	63,156	58,678	62,311
Other Receivables	6,707	6,303	7,444	6,362	6,241	7,122
Receivables	75,056	69,004	67,595	69,518	64,945	69,476
Inventory	76,553	61,725	61,370	41,190	48,590	53,450
Prepaid Expenses	146.3	186.42	303.23	515.3	640.96	209.93
Other Current Assets	3,893	8,390	6,443	10,261	6,707	12,374
Total Current Assets	180,273	159,066	200,728	203,560	162,496	171,407
Property, Plant & Equipment	211,962	199,478	199,118	198,307	185,966	182,047
Long-Term Investments	3,577	4,340	1,451	1,598	2,513	3,360
Other Intangible Assets	4,679	4,371	4,534	3,746	3,654	3,960
Long-Term Deferred Charges	75,315	71,154	70,364	61,418	55,747	48,044
Other Long-Term Assets	20,859	21,046	21,991	25,643	28,742	28,637
Total Assets	496,665	459,456	498,185	494,271	439,117	437,456
Accounts Payable	37,392	31,495	37,630	26,856	23,663	25,271
Accrued Expenses	424.18	398.44	310.58	314.19	173.36	233.74
Short-Term Debt	91,049	78,248	82,612	96,058	84,256	97,663
Current Portion of Long-Term Debt	-	-	2,000	-	18,485	12,000
Current Portion of Leases	371.1	522.11	370.52	159.24	-	-
Current Income Taxes Payable	957.73	2,404	4,974	8,617	3,976	2,751
Other Current Liabilities	74,847	60,606	58,962	66,206	46,594	42,410
Total Current Liabilities	205,040	173,674	186,859	198,210	177,147	180,329
Long-Term Debt	6,000	6,000	-	5,000	-	18,465
Long-Term Leases	298.06	339.24	732.69	843.73	300.62	440.29
Long-Term Deferred Tax Liabilities	9,031	9,043	10,330	10,302	7,962	7,756
Other Long-Term Liabilities	310	50	500	21.5	0	0
Total Liabilities	228,309	196,428	206,331	222,513	194,195	214,717
Common Stock	47,714	47,714	47,714	47,714	47,714	47,714
Additional Paid-In Capital	78,430	78,441	78,416	78,590	78,795	78,473
Retained Earnings	53,988	53,653	58,989	43,547	31,413	20,970
Treasury Stock	-11,801	-11,921	-10,075	-7,437	-7,743	-7,208
Comprensive Income & Other	59,893	57,957	58,496	60,587	55,902	55,836
Total Common Equity	228,225	225,844	233,541	223,002	206,081	195,785
Minority Interest	39,019	36,071	57,200	47,643	37,728	25,842
Shareholders' Equity	268,356	263,028	291,854	271,758	244,922	222,739
Total Liabilities & Equity	496,665	459,456	498,185	494,271	439,117	437,456
Total Debt	97,718	85,110	85,715	102,061	103,041	128,568
Net Cash (Debt)	-73,093	-65,349	-20,699	-19,986	-61,429	-92,671
Net Cash Per Share	-4067.07	-3626.71	-1142.00	-1097.82	-3374.26	-5090.39
Filing Date Shares Outstanding	17.97	17.97	18.09	18.21	18.21	18.21
Total Common Shares Outstanding	17.97	17.97	18.09	18.21	18.21	18.21
Working Capital	-24,767	-14,608	13,868	5,350	-14,651	-8,922
Book Value Per Share	12699.06	12566.60	12912.19	12249.38	11319.92	10754.36
Tangible Book Value	223,545	221,473	229,007	219,256	202,427	191,825
Tangible Book Value Per Share	12438.68	12323.37	12661.52	12043.60	11119.20	10536.83
Land	120,507	120,298	120,308	116,955	102,083	101,168
Buildings	54,185	54,753	58,660	55,981	57,001	55,753
Machinery	10,989	11,599	16,022	12,574	14,843	17,482
Construction In Progress	24,951	11,435	2,384	11,360	11,144	6,365

Source: S&P Capital IQ. Standard template. Financial Sources.